What is Synthetic Control Arm?
TL;DR
A method in clinical trials that constructs a control group from AI or historical data instead of a real placebo arm—reducing patient burden and allocating more patients to the active treatment.
Synthetic Control Arm: Definition & Explanation
A synthetic control arm (also external control arm) is a method in clinical trials that replaces some or all of an actual placebo control group with historical trial data, real-world data, or an AI prediction model (digital twin). Companies like Unlearn.AI and Medidata pursue it, and it is one of the most-watched approaches in 2026 trial transformation.\n\nIn a standard randomized controlled trial, roughly half of subjects are assigned to placebo, which exposes patients to ineffective treatment and increases the required sample size. With a synthetic control arm, the control group can be shrunk and more patients allocated to the active arm, reducing patient burden, easing recruitment, and shortening trial timelines.\n\nAt the same time, how to correct for differences between historical data and the current trial population (confounding and selection bias), and how far regulators (FDA, EMA, PMDA) will accept synthetic control arms as a basis for approval, remain evolving questions. Use is especially anticipated in areas where securing a placebo arm is ethically or practically difficult, such as rare diseases and pediatrics.